LIANY — LianBio Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-JetBlue Airways, LPL Financial, Nvidia
U.S. STOCKS ON THE MOVE-Bicycle Therapeutics, Molson Coors, LianBio
LianBio completes strategic review, cuts jobs; shares up
Brief: LianBio Announces Completion Of Strategic Review
Reneo Pharma up on acquisition offer from Concentra Biosciences
Brief: LianBio Says Co, LianBio Development And Janssen Pharmaceutica NV Entered Into Asset Purchase Agreement
Brief: LianBio Says Enters Into Agreement Assigning Its Rights For NBTXR3 In China And Other Asian Markets
Brief: Lianbio Announces Departure Of Chief Financial Officer
Brief: Lianbio Announces Departure Of Chief Executive Officer
Brief: Lianbio’S Board Of Directors Unanimously Determines Not To Pursue Unsolicited Proposal From Concentra Biosciences
Brief: Lianbio Confirms Receipt Of Unsolicited Proposal From Concentra Biosciences
U.S. RESEARCH ROUNDUP-Amgen, Fiserv, Visa
U.S. STOCKS ON THE MOVE-TransUnion, Boeing, Editas
U.S. STOCKS ON THE MOVE-LianBio, HCA, Nike
LianBio jumps on agreement with Bristol Myers Squibb for heart disease drug
Brief: LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets
Brief: LianBio Announces Results From Phase 3 EXPLORER-CN Trial Of Mavacamten Presented At The European Society Of Cardiology Congress
Brief: LianBio Q2 operating expenses USD 25.044 million
LianBio reports results for the quarter ended in June - Earnings Summary